Propanc Biopharma, Inc.

Latest News

Oct 4, 2018

Propanc Biopharma Initiates European Validation of its Lead Patent

MELBOURNE, Australia, Oct. 4, 2018 /PRNewswire/ -- Propanc Biopharma, Inc. (OTCQB: PPCB) ("Propanc Biopharma" or the "Company"), a clinical stage biopharmaceutical company focusing on development of new and…

View All Press Releases

Sep 19, 2018

Propanc Biopharma Enters into Research Collaboration Agreement with the University of Jaén

Sep 12, 2018

Propanc Biopharma Provides Shareholder Update after Presenting at the 25th Annual NewsMakers in the Biotech Industry Conference

Aug 9, 2018

Propanc Biopharma Selected to Present at the 25th Annual NewsMakers in the Biotech Industry
Latest Publication Antitumour efficacy of chymotrypsinogen and trypsinogen View All Publications
In vitro treatment of carcinoma cell lines with pancreatic (pro)enzymes suppresses the EMT programme and promotes cell differentiation
A formulation of pancreatic pro-enzymes provides potent anti-tumour efficacy: a pilot study focused on pancreatic and ovarian cancer